AZ Liver’s own Vicki McIntyre, DNP, FNP was featured on the popular Tucson morning show “The Morning Blend” last month where she discussed several topics including:

As part of its mission to educate the community about liver health, AZ Liver Health has created a large, inflatable educational tool to bring the liver to life. The nearly 12-foot tall liver highlights the major anatomy of the liver …

This article provides expert guidance on the management of pruritus symptoms in patients receiving obeticholic acid (OCA) as treatment for primary biliary cholangitis (PBC).

In this review we critically assess the literature to evaluate the level of risk posed by alcohol as both a primary etiology of hepatocellular carcinoma (HCC) and

Abstract: Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon.

The interferon (IFN)–free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1.

Our very own Ann Moore joins Wayne Eskridge to discuss advances in liver disease screening technology.

If you’re a liver patient, your diet is adjusted to meet your individual needs. Talk to your doctor about what’s best for you. Still, here are some general food tips for a healthy or healthier liver:

Join GP and Medical Educator Dr Sam Manger MBBS BSc FRACGP FASLM covering a variety of topics with case studies, guideline reviews, guest interviews and more for medical doctors and allied…

Watch author, Anita Kohli, MD, discuss “Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse. An Open-Label Pilot Study.”